Consolidated Balance Sheets - USD ($) $ in Millions	Jun. 30, 2023	Dec. 31, 2022
Investments:
Fixed maturity available-for-sale securities, at fair value (amortized cost: 2023 - $111,354; 2022 - $111,707; allowance for credit losses: 2023 - $25; 2022 - $22)	$ 100,890	$ 99,736
Trading securities	2,943	3,498
Equity securities	403	427
Mortgage loans on real estate, net of allowance for credit losses (portion at fair value: 2023 - $404; 2022 - $487)	18,460	18,301
Policy loans	2,423	2,359
Derivative investments	5,155	3,594
Other investments	4,195	3,739
Total investments	134,469	131,654
Cash and invested cash	3,768	3,343
Deferred acquisition costs, value of business acquired and deferred sales inducements	12,316	12,235
Reinsurance recoverables, net of allowance for credit losses	19,030	19,443
Market risk benefit assets	3,906	2,807
Accrued investment income	1,277	1,253
Goodwill	1,144	1,144
Other assets	19,456	18,802
Separate account assets	153,246	143,536
Total assets	348,612	334,217
Liabilities
Policyholder account balances	117,598	114,435
Future contract benefits	39,711	38,826
Market risk benefit liabilities	1,548	2,078
Deferred front-end loads	5,450	5,052
Payables for collateral on investments	7,062	6,712
Short-term debt	500	500
Long-term debt	5,954	5,955
Other liabilities	11,724	12,021
Separate account liabilities	153,246	143,536
Total liabilities	342,793	329,115
Contingencies and Commitments (See Note 14)
Stockholders' Equity
Common stock – 800,000,000 shares authorized; 169,630,880 and 169,220,511 shares issued and outstanding as of June 30, 2023, and December 31, 2022, respectively	4,575	4,544
Retained earnings	5,362	5,924
Accumulated other comprehensive income (loss)	(5,104)	(6,352)
Total stockholders' equity	5,819	5,102
Total liabilities and stockholders' equity	348,612	334,217
Series C Preferred Stock [Member]
Stockholders' Equity
Preferred stock - 10,000,000 shares authorized	493	493
Series D Preferred Stock [Member]
Stockholders' Equity
Preferred stock - 10,000,000 shares authorized	$ 493	$ 493